JANUVIA®

Drug Information Related Patent
Hold Company
MERCK SHARP DOHME
Dosage and Administration
TABLET;ORAL
Specification
EQ 25MG BASE; EQ 50MG BASE; EQ 100MG BASE
Indication
JANUVIA® can be used as auxiliary diet and exercise, so as to improve the adult type Ⅱ the glycemic control of diabetic patients.
API
SITAGLIPTIN PHOSPHATE
API Structure
Drug Patent
Patent NoExpiration Date
73267082026/11/24
7326708*PED2027/5/24
API Patent
Patent NoExpiration Date
73267082026/11/24
7326708*PED2027/5/24
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top